Our research focuses on designing, synthesizing, and analyzing potential inhibitors of Vibrio bacteria that cause disease in marine animals and humans. Our previous studies identified thiophenesulfonamide compounds as potent inhibitors of pathogenicity in Vibrio species. We aim to develop compounds for the treatment of Vibrio disease.
We have synthesized a panel of thiophenesulfonamide molecules active against several Vibrio species. We've solved the X-ray crystal structure of a thiophenesulfonamide molecule in the binding pocket of the target Vibrio. And we determined the thiophenesulfonamide mechanism of action in blocking the protein target and preventing pathogenicity in vivo.
This protocol is designed with the novice researcher in mind. Every step was optimized for simplicity and error reduction, while still allowing for teaching concepts and the scientific method. Our protocol bridges microbiology, organic chemistry, structure modeling, and drug design in a novel, teaching-based experimental system.
Novel therapeutics that target Vibrio bacteria are needed to treat the increasing cases of Vibriosis in humans and aquaculture. Because our compounds are not antibiotics and don't kill cells, they have the potential to treat disease without generating resistance. We will focus on optimizing the inhibitors of Vibrio species that do not have a therapeutically relevant inhibitor yet.
We will also explore the chemical space afforded by substituted aromatic sulfonyl chloride starting materials.